Arbutus Biopharma (ABUS) Amortizatization of Intangibles (2019 - 2025)
Arbutus Biopharma (ABUS) has disclosed Amortizatization of Intangibles for 7 consecutive years, with $422000.0 as the latest value for Q4 2025.
- Quarterly Amortizatization of Intangibles fell 54.28% to $422000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.3 million through Dec 2025, down 25.07% year-over-year, with the annual reading at $2.3 million for FY2025, 25.07% down from the prior year.
- Amortizatization of Intangibles hit $422000.0 in Q4 2025 for Arbutus Biopharma, down from $541000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $983000.0 in Q3 2024 to a low of -$300000.0 in Q3 2021.
- Historically, Amortizatization of Intangibles has averaged $336750.0 across 5 years, with a median of $478000.0 in 2023.
- Biggest five-year swings in Amortizatization of Intangibles: crashed 8050.0% in 2021 and later surged 743.37% in 2023.
- Year by year, Amortizatization of Intangibles stood at -$246000.0 in 2021, then surged by 191.06% to $224000.0 in 2022, then soared by 176.34% to $619000.0 in 2023, then skyrocketed by 49.11% to $923000.0 in 2024, then tumbled by 54.28% to $422000.0 in 2025.
- Business Quant data shows Amortizatization of Intangibles for ABUS at $422000.0 in Q4 2025, $541000.0 in Q3 2025, and $668000.0 in Q2 2025.